Kenro Tanoue
Fukuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Metastatic urachal carcinoma treated with trifluridine/tipiracil and bevacizumab: a case report.
Journal: International cancer conference journal
Published: February 12, 2025
A phase I/II trial evaluating the safety of increased-dose S- 1 with oxaliplatin and nivolumab in HER2-negative advanced gastric cancer.
Journal: BMC cancer
Published: June 24, 2024
Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced Gastric Cancer.
Journal: JCO precision oncology
Published: May 15, 2024
Spatial dynamics of CD39+CD8+ exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer.
Journal: Nature communications
Published: December 13, 2023
Preferential B cell differentiation by combined immune checkpoint blockade for renal cell carcinoma is associated with clinical response and autoimmune reactions.
Journal: Cancer immunology, immunotherapy : CII
Published: February 01, 2023
Presence of spontaneous epithelial-mesenchymal plasticity in esophageal cancer.
Journal: Biochemistry and biophysics reports
Published: January 20, 2022
Prominent PD-L1-positive M2 macrophage infiltration in gastric cancer with hyper-progression after anti-PD-1 therapy: A case report.
Journal: Medicine
Published: January 28, 2021
Predictive impact of C-reactive protein to albumin ratio for recurrent or metastatic head and neck squamous cell carcinoma receiving nivolumab.
Journal: Scientific reports
Published: October 23, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026